• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Global Contraceptives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
 

Global Contraceptives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018

on

  • 780 views

Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report ...

Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market.

Statistics

Views

Total Views
780
Views on SlideShare
780
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Global Contraceptives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018 Global Contraceptives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018 Document Transcript

    • REPORT DESCRIPTIONGlobal Contraceptives Market - Global Industry Analysis, Size, Share, Growth AndForecast, 2012 - 2018Contraceptive drugs and devices are temporary birth control methods and function majorlyby altering the mechanism of ovulation and acting as physical barriers between the spermand ovary. This report holds the market estimation of the global contraceptives market interms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as.In addition, current market trends and recent developments are taken into considerationwhile determining the growth rate of the global contraceptives market.The overall contraceptives market is categorized on the basis of products into two majorcategories namely contraceptive drugs and contraceptive devices. The contraceptive drugsmarket is further sub-segmented into contraceptive pills, injectables and contraceptivesponges and the contraceptive devices market is sub-segmented into male and femalecontraceptive devices. The male contraceptive devices consist of male condoms and thefemale contraceptive devices consist of female condoms, diaphragms, sponges, vaginalrings, subdermal contraceptive implants and intra uterine devices (copper and hormonal).Transparency Market ResearchGlobal ContraceptivesMarket - Global IndustryAnalysis, Size, Share,Growth And Forecast, 2012- 2018Single User License: US $ 4595Multi User License: US $ 7595Corporate User License: US $ 10595Buy NowRequest SamplePublished Date: MAY 201393 Pages Report
    • Browse Report : Global Contraceptives MarketThe market for all these segments and sub-segments is estimated for the period 2012 –2018 in terms of value (USD million).The market is also forecasted in terms of value (USD million) for the period 2012 – 2018 forfour major geographic regions namely North America, Asia-Pacific, Europe and the rest ofthe world.Some of the key market players of the global contraceptives market include Merck, BayerHealthCare, Church & Dwight, Warner Chilcott Company, Inc., Pfizer, Agile Therapeutics,Biosante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience and TevaPharmaceuticals. Market players are profiled in this report on the basis of parameters suchas company overview, business strategies adopted by the companies to ensuresustainability and maximize profits, financial overview and recent developments.The global contraceptive market is categorized into the following segments Contraceptives Market by Productso Contraceptive Drugs Oral Contraceptive Pills Contraceptive Injectables Topical Contraceptiveso Contraceptive Devices Male Contraceptive Devices (Male Condoms) Female Contraceptive Devices Female Condoms Diaphragms Sponges IUDs Hormonal IUDs Copper IUDs Subdermal Contraceptive Implants Vaginal Rings
    •  Contraceptives Market by Geographyo North Americao Europeo Asia-Pacifico Rest of the World (RoW)TABLE OF CONTENTSChapter 1 Preface1.1 Report Description1.2 Research Methodology1.3 Market SegmentationChapter 2 Executive SummaryChapter 3 Market Overview3.1 Market Dynamics3.1.1 Market Drivers3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalenceof Women with Unmet Contraceptive Needs3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market3.1.3 Market Restraints3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market3.1.5 Market Opportunities
    • Browse Report : http://www.transparencymarketresearch.com/contraceptives-market.html3.1.5.1 Presence of Strong Contraceptives Pipeline3.1.5.1.1 Male Contraceptive Drugs3.1.5.1.2 AG200-15 Topical Contraceptive Patch3.1.5.1.3 FC Patch Low3.1.5.1.4 Pill-Plus3.1.5.1.5 Other Products in Pipeline3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian andAfrican Economies3.2 Porter’s Five Forces Analysis: Global Contraceptives Market3.2.1 Bargaining Power of Suppliers3.2.2 Bargaining Power of Buyers3.2.3 Threat of New Entrants3.2.4 Threat of Substitutes3.2.5 Competitive Rivalry3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)Chapter 4 Global Contraceptives Market, by Products4.1 Overview4.2 Global Contraceptive Drugs Market4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)4.2.2 Global Oral Contraceptive Pills Market4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 20114.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)4.2.3 Global Contraceptive Injectables Market4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011
    • 4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)4.2.4 Global Topical Contraceptives Market4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)4.3 Global Contraceptive Devices Market4.3.1 Global Male Contraceptive Devices (Male Condoms) Market4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (MaleCondoms) Market4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018(USD Million)4.3.2 Global Female Contraceptive Devices Market4.3.2.1 Global Female Condoms Market4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)4.3.2.2 Global Contraceptive Diaphragms Market4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USDMillion)4.3.2.3 Global Contraceptive Sponges Market4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USDMillion)4.3.2.4 Global Contraceptive Vaginal Rings Market4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USDMillion)4.3.2.5 Global Intrauterine Devices (IUD) Market4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)4.3.2.5.3 Competitive Landscape: Global IUD Market, 20114.3.2.6 Global Sub-dermal Contraceptive Implants Market4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 –2018 (USD Million)
    • 4.3.2.6.2 Competitive Landscape: Global Sub-dermal ContraceptiveImplants MarketBrowse Report : http://www.transparencymarketresearch.com/contraceptives-market.htmlChapter 5 Global Contraceptives Market, by Geography5.1 Overview5.2 North America Contraceptives Market5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018(USD Million)5.3 Europe Contraceptives Market5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USDMillion)5.4 Asia-Pacific Contraceptives Market5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018(USD Million)5.5 Rest of the World (RoW) Contraceptives Market5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USDMillion)Chapter 6 Recommendations6.1 Investing in Emerging Economies such as India and China and Underdeveloped AfricanEconomies6.2 Making Rigorous R&D Initiatives6.3 Investing in Marketing Campaigns to Elevate Customer Awareness6.4 Tracking patent expiration of Branded Product
    • Chapter 7 Company Profiles7.1 Merck & Co.7.1.1 Company Profile7.1.2 Financial Overview7.1.3 Product Portfolio7.1.4 Business Strategy7.1.5 Recent Developments7.2 Bayer HealthCare AG7.2.1 Company Profile7.2.2 Financial Overview7.2.3 Product Portfolio7.2.4 Business Strategy7.2.5 Recent Developments7.3 Church & Dwight, Co. Inc.7.3.1 Company Profile7.3.2 Financial Overview7.3.3 Product Portfolio7.3.4 Business Strategy7.3.5 Recent Developments7.4 Warner Chilcott Company, Inc.7.4.1 Company Profile7.4.2 Financial Overview7.4.3 Product Portfolio7.4.4 Business Strategy7.4.5 Recent Developments7.5 Pfizer, Inc.7.5.1 Company Overview
    • Browse Report : http://www.transparencymarketresearch.com/contraceptives-market.html7.5.2 Financial Overview7.5.3 Product Portfolio7.5.4 Business Strategy7.5.5 Recent Developments7.6 Agile Therapeutics Inc.7.6.1 Company Overview7.6.2 Business Strategy7.6.3 Product Portfolio7.6.4 Recent Developments7.7 BioSante Pharmaceuticals Inc.7.7.1 Company Overview7.7.2 Financial Overview7.7.3 Business Strategy7.7.4 Product Portfolio7.7.5 Recent Developments7.8 Mayer Laboratories, Inc.7.8.1 Company Overview7.8.2 Business Strategy7.8.3 Product Portfolio7.8.4 Recent Developments7.9 Pantarhei Bioscience B.V.7.9.1 Company Overview7.9.2 Business Strategy7.9.3 Product Portfolio
    • 7.9.4 Recent Developments7.10 Teva Pharmaceutical Industries Ltd.7.10.1 Company Overview7.10.2 Financial Overview7.10.3 Business Strategy7.10.4 Product Portfolio7.10.5 Recent DevelopmentsAbout Us:Transparency Market Research is a market intelligence company providing global businessinformation reports and services. Our exclusive blend of quantitative forecasting and trendsanalysis provides forward-looking insight for thousands of decision makers.We are privileged with highly experienced team of Analysts, Researchers and Consultants,who use proprietary data sources and various tools and techniques to gather, and analyzeinformation. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:Transparency Market Research90 State Street,Suite 700,AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/